Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist

Nephrology

Volumn 16, Issue 2, 2011, Pages 125-133

  Mulley, William R ^a,b   Kanellis, John ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

antibody specificity; crossmatching; flow cytometry; graft rejection; kidney transplantation; tissue

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1; HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY MEDIATED REJECTION; ANTIGEN BINDING; CASE REPORT; COMPLEMENT DEPENDENT CYTOTOXICITY; CROSS MATCH TEST; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; HLA MATCHING; HUMAN; IMMUNOGENICITY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROLOGIST; PLASMAPHERESIS; PRIORITY JOURNAL; REFLUX NEPHROPATHY; REVIEW; TISSUE TYPING;

ANTIBODIES; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION;

EID: 79551509382     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01414.x     Document Type: Review

References (33)

1. Terasaki PI,. Humoral theory of transplantation. Am. J. Transplant. 2003; 3: 665.
2. Cai J, Terasaki PI,. Humoral theory of transplantation: Mechanism, prevention, and treatment. Hum. Immunol. 2005; 66: 334.
3. Patel R, Terasaki PI,. Significance of the positive crossmatch test in kidney transplantation. N Engl. J. Med. 1969; 280: 735.
4. Bryan CF, Martinez J, Muruve N, et al. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype. Clin. Transplant. 2001; 15 (Suppl 6): 28.
5. Kerman RH, Susskind B, Buyse I, et al. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation 1999; 68: 1855.
6. McCalmon RT Jr, Tardif GN, Sheehan MA, Fitting K, Kortz W, Ig KI,. M antibodies in renal transplantation. Clin. Transplant. 1997; 11: 558.
7. Tardif GN, McCalmon RT Jr,. Successful renal transplantation in the presence of donor specific HLA IgM antibodies. Transplant. Proc. 1995; 27 (1): 664.
8. Terasaki PI, McClelland JD,. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998.
9. Danovitch GM,. Handbook of Kidney Transplantation, 4th edn. Philadelphia: Lippincott William & Wilkins, 2005.
10. Pellegrino MA, Belvedere M, Pellegrino AG, Ferrone S,. B peripheral lymphocytes express more HLA antigens than T peripheral lymphocytes. Transplantation 1978; 25: 93.
11. Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S,. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am. J. Transplant. 2006; 6: 346.
12. Mahoney RJ, Taranto S, Edwards E,. B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients. Hum. Immunol. 2002; 63: 324.
13. Le Bas-Bernardet S, Hourmant M, Valentin N, et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003; 75: 477.
14. Pollinger HS, Stegall MD, Gloor JM, et al. Kidney transplantation in patients with antibodies against donor HLA class II. Am. J. Transplant. 2007; 7 (4): 857.
15. Eng HS, Bennett G, Tsiopelas E, et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am. J. Transplant. 2008; 8 (11): 2335.
16. Karpinski M, Rush D, Jeffery J, et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J. Am. Soc. Nephrol. 2001; 12 (12): 2807.
17. Bryan CF, Baier KA, Nelson PW, et al. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Transplantation 1998; 66: 1827.
18. Garovoy MRRM, Bigos M, Perkins H, Colombe BFN, Salvatierra O,. Flow cytometry analysis: A high technology crossmatch technique facilitating transplantation. Transplant. Proc. 1983; XV: 1939.
19. Vaidya S, Partlow D, Susskind B, Noor M, Barnes T, Gugliuzza K,. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 2006; 82: 1524.
20. Limaye S, O'Kelly P, Harmon G, et al. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch. Transplantation 2009; 87: 1052.
21. Christiaans MH, Overhof R, ten Haaft A, Nieman F, van Hooff JP, van den Berg-Loonen EM,. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 1996; 62: 1341.
22. Ilham MA, Winkler S, Coates E, Rizzello A, Rees TJ, Asderakis A,. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants. Transplant. Proc. 2008; 40 (6): 1839.
23. Amico P, Honger G, Mayr M, Steiger J, Hopfer H, Schaub S,. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009; 87: 1681.
24. Terasaki PI, Ozawa M, Castro R,. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am. J. Transplant. 2007; 7 (2): 408.
25. Bielmann D, Honger G, Lutz D, Mihatsch MJ, Steiger J, Schaub S,. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am. J. Transplant. 2007; 7 (3): 626.
26. Tait BD, Hudson F, Cantwell L, et al. Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology (Carlton) 2009; 14: 247.
27. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI,. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003; 75: 43.
28. Terasaki PI, Kreisler M, Mickey RM,. Presensitization and kidney transplant failures. Postgrad. Med. J. 1971; 47 (544): 89.
29. Tambur AR, Ramon DS, Kaufman DB, et al. Perception versus reality?: Virtual crossmatch-How to overcome some of the technical and logistic limitations. Am. J. Transplant. 2009; 9 (8): 1886.
30. Mizutani K, Terasaki P, Hamdani E, et al. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am. J. Transplant. 2007; 7 (4): 1027.
31. Zachary AA, Lucas DP, Detrick B, Leffell MS,. Naturally occurring interference in Luminex assays for HLA-specific antibodies: Characteristics and resolution. Hum. Immunol. 2009; 70: 496.
32. Morris GP, Phelan DL, Jendrisak MD, Mohanakumar T,. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: A 30-month analysis in living donor kidney transplantation. Hum. Immunol. 2010; 71 (3): 268.
33. Augustine JJ, Siu DS, Clemente MJ, Schulak JA, Heeger PS, Hricik DE,. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am. J. Transplant. 2005; 5 (8): 1971.